Literature DB >> 14532227

National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites.

Christopher P Barrozo1, Kevin L Russell, Tyler C Smith, Anthony W Hawksworth, Margaret A K Ryan, Gregory C Gray.   

Abstract

Antibiotic resistance and emm gene types were examined from 692 Group A streptococci isolates from eight United States military basic training sites between 1998 and 2001. Macrolide resistance was associated with geographic sites and emm type. These data are useful for vaccine development initiatives and antimicrobial treatment considerations.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14532227      PMCID： PMC254343          DOI： 10.1128/JCM.41.10.4808-4811.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  29 in total

1.  Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis.

Authors:  E L Kaplan; J T Wotton; D R Johnson
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  The emergence of erythromycin-resistant Streptococcus pyogenes in Seoul, Korea.

Authors:  S Cha; H Lee; K Lee; K Hwang; S Bae; Y Lee
Journal:  J Infect Chemother       Date:  2001-06       Impact factor: 2.211

3.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.

Authors:  D J Hoban
Journal:  J Chemother       Date:  2002-07       Impact factor: 1.714

5.  Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.

Authors:  P K Peterson; D Schmeling; P P Cleary; B J Wilkinson; Y Kim; P G Quie
Journal:  J Infect Dis       Date:  1979-05       Impact factor: 5.226

6.  Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.

Authors:  Richard F Facklam; Diana R Martin; Marguerite Lovgren; Dwight R Johnson; Androulla Efstratiou; Terry A Thompson; Sonia Gowan; Paula Kriz; Gregory J Tyrrell; Edward Kaplan; Bernard Beall
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

7.  Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh.

Authors:  Judith M Martin; Michael Green; Karen A Barbadora; Ellen R Wald
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

8.  Distribution of emm genotypes and superantigen genes of Streptococcus pyogenes isolated in Japan, 1994-9.

Authors:  J Murakami; S Kawabata; Y Terao; K Kikuchi; K Totsuka; A Tamaru; C Katsukawa; K Moriya; I Nakagawa; I Morisaki; S Hamada
Journal:  Epidemiol Infect       Date:  2002-06       Impact factor: 2.451

9.  Erythromycin resistance in Streptococcus pyogenes in Italy.

Authors:  M Bassetti; G Manno; A Collidà; A Ferrando; G Gatti; E Ugolotti; M Cruciani; D Bassetti
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

10.  emm typing and validation of provisional M types for group A streptococci.

Authors:  R Facklam; B Beall; A Efstratiou; V Fischetti; D Johnson; E Kaplan; P Kriz; M Lovgren; D Martin; B Schwartz; A Totolian; D Bessen; S Hollingshead; F Rubin; J Scott; G Tyrrell
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883
View more
  4 in total

1.  M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns.

Authors:  Wezenet Tewodros; Göran Kronvall
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.

Authors:  Iris Chen; Pakieli Kaufisi; Guliz Erdem
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

3.  Adverse events following mass antibiotic prophylaxis during a Group A Streptococcus outbreak in the Canadian Forces Leadership and Recruit School.

Authors:  Diane Lu; Barbara Strauss; Kristen Simkus; Martin Tepper; François Gagnon; Noémie Johnson; Eric Girard; Kirsten Barnes
Journal:  Can Commun Dis Rep       Date:  2020-09-03

4.  Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Authors:  Joshua M Klonoski; Heather R Hurtig; Brian A Juber; Margaret J Schuneman; Thomas E Bickett; Joshua M Svendsen; Brandon Burum; Thomas A Penfound; Grigoriy Sereda; James B Dale; Michael S Chaussee; Victor C Huber
Journal:  Vaccine       Date:  2014-07-29       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.